Search for other papers by Bernardo Maia in
Google Scholar
PubMed
Neuroendocrinology Division – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil
Endocrinology Division – Hospital Federal de Bonsucesso, Rio de Janeiro Brazil
Search for other papers by Leandro Kasuki in
Google Scholar
PubMed
Neuroendocrinology Division – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil
Neuropatology and Molecular Genetics Laboratory – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil
Search for other papers by Mônica R Gadelha in
Google Scholar
PubMed
: Personalized medicine in the treatment of acromegaly . European Journal of Endocrinology 2018 178 R89 – R100 . ( https://doi.org/10.1530/EJE-17-1006 ) 64 Cuevas-Ramos D Fleseriu M Pasireotide: a novel treatment for patients with acromegaly . Drug
Search for other papers by Tatsuya Kondo in
Google Scholar
PubMed
Search for other papers by Nobukazu Miyakawa in
Google Scholar
PubMed
Search for other papers by Sayaka Kitano in
Google Scholar
PubMed
Search for other papers by Takuro Watanabe in
Google Scholar
PubMed
Search for other papers by Rieko Goto in
Google Scholar
PubMed
Search for other papers by Mary Ann Suico in
Google Scholar
PubMed
Search for other papers by Miki Sato in
Google Scholar
PubMed
Search for other papers by Yuki Takaki in
Google Scholar
PubMed
Search for other papers by Masaji Sakaguchi in
Google Scholar
PubMed
Search for other papers by Motoyuki Igata in
Google Scholar
PubMed
Search for other papers by Junji Kawashima in
Google Scholar
PubMed
Search for other papers by Hiroyuki Motoshima in
Google Scholar
PubMed
Search for other papers by Takeshi Matsumura in
Google Scholar
PubMed
Search for other papers by Hirofumi Kai in
Google Scholar
PubMed
Search for other papers by Eiichi Araki in
Google Scholar
PubMed
novel treatment strategy for NAFLD as well as metabolic disorders, including metabolic syndrome and type 2 diabetes. Supplementary materials This is linked to the online version of the paper at https://doi.org/10.1530/EC-21
Dipartimento di Medicina Clinica e Chirurgia, Università Federico II, Naples, Italy
Search for other papers by Maria Cristina De Martino in
Google Scholar
PubMed
Search for other papers by Richard A Feelders in
Google Scholar
PubMed
Search for other papers by Claudia Pivonello in
Google Scholar
PubMed
Search for other papers by Chiara Simeoli in
Google Scholar
PubMed
Search for other papers by Fortuna Papa in
Google Scholar
PubMed
Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Search for other papers by Rosario Pivonello in
Google Scholar
PubMed
Search for other papers by Leo J Hofland in
Google Scholar
PubMed
and growth factor signaling pathways represent a potential novel treatment option for the management of patients with ACCs. The mTOR pathway, being involved in both these processes, could represent a potential target for treatment of these malignancies
Search for other papers by R C S van Adrichem in
Google Scholar
PubMed
Search for other papers by L J Hofland in
Google Scholar
PubMed
Search for other papers by R A Feelders in
Google Scholar
PubMed
Search for other papers by M C De Martino in
Google Scholar
PubMed
Search for other papers by P M van Koetsveld in
Google Scholar
PubMed
Search for other papers by C H J van Eijck in
Google Scholar
PubMed
Search for other papers by R R de Krijger in
Google Scholar
PubMed
Search for other papers by D M Sprij-Mooij in
Google Scholar
PubMed
Search for other papers by J A M J L Janssen in
Google Scholar
PubMed
Search for other papers by W W de Herder in
Google Scholar
PubMed
.1016/S1470-2045(07)70410-2 ). 2 Hopfner M Baradari V Huether A Schofl C Scherubl H . The insulin-like growth factor receptor 1 is a promising target for novel treatment approaches in neuroendocrine gastrointestinal tumours . Endocrine
Search for other papers by Carina Hasenoehrl in
Google Scholar
PubMed
Search for other papers by Gert Schwach in
Google Scholar
PubMed
SFL Chicken CAM Lab, Institute of Pathophysiology and Immunology, Medical University of Graz, Graz, Austria
Search for other papers by Nassim Ghaffari-Tabrizi-Wizsy in
Google Scholar
PubMed
Search for other papers by Robert Fuchs in
Google Scholar
PubMed
Search for other papers by Nadine Kretschmer in
Google Scholar
PubMed
Search for other papers by Rudolf Bauer in
Google Scholar
PubMed
Search for other papers by Roswitha Pfragner in
Google Scholar
PubMed
medullary thyroid carcinoma is a rare hormone-producing tumor, it accounts for 13.4% of deaths attributable to thyroid cancers ( 22 ). As MTC does not respond to conventional therapy, novel treatment options are needed ( 1 , 2 , 8 , 23 ) and compounds
Search for other papers by Xiao-Ping Qi in
Google Scholar
PubMed
Search for other papers by Jian-Zhong Peng in
Google Scholar
PubMed
Search for other papers by Xiao-Wei Yang in
Google Scholar
PubMed
Search for other papers by Zhi-Lie Cao in
Google Scholar
PubMed
Search for other papers by Xiu-Hua Yu in
Google Scholar
PubMed
Search for other papers by Xu-Dong Fang in
Google Scholar
PubMed
Search for other papers by Da-Hong Zhang in
Google Scholar
PubMed
Search for other papers by Jian-Qiang Zhao in
Google Scholar
PubMed
: novel treatment with fractional ablative 2,940 nm erbium: YAG laser treatment . Journal of Cutaneous and Aesthetic Surgery 2012 5 141 – 143 . ( https://doi.org/10.4103/0974-2077.99459 ) 23060710 10.4103/0974-2077.99459 32 Elisei R Romei C
Search for other papers by Wolfgang Koechling in
Google Scholar
PubMed
Search for other papers by Daniel Plaksin in
Google Scholar
PubMed
Search for other papers by Glenn E Croston in
Google Scholar
PubMed
Search for other papers by Janni V Jeppesen in
Google Scholar
PubMed
Search for other papers by Kirsten T Macklon in
Google Scholar
PubMed
Search for other papers by Claus Yding Andersen in
Google Scholar
PubMed
increasingly common due to safety and convenience ( 3 ). As a result, continued innovation in infertility therapy is likely to involve both novel FSH proteins and novel treatment protocols. FSH is composed of two extensively glycosylated protein subunits, and
Search for other papers by Heike Hoyer-Kuhn in
Google Scholar
PubMed
Search for other papers by Angela Huebner in
Google Scholar
PubMed
Search for other papers by Anette Richter-Unruh in
Google Scholar
PubMed
Search for other papers by Markus Bettendorf in
Google Scholar
PubMed
Search for other papers by Tilman Rohrer in
Google Scholar
PubMed
Search for other papers by Klaus Kapelari in
Google Scholar
PubMed
St.Anna Kinderspital, Medical University of Vienna, Vienna, Austria
Search for other papers by Stefan Riedl in
Google Scholar
PubMed
Search for other papers by Klaus Mohnike in
Google Scholar
PubMed
Search for other papers by Helmuth-Günther Dörr in
Google Scholar
PubMed
Search for other papers by Friedrich-Wilhelm Roehl in
Google Scholar
PubMed
Search for other papers by Katharina Fink in
Google Scholar
PubMed
Search for other papers by Reinhard W Holl in
Google Scholar
PubMed
Search for other papers by Joachim Woelfle in
Google Scholar
PubMed
://doi.org/10.1530/EC-18-0281 ) 5 Turcu AF Auchus RJ Novel treatment strategies in congenital adrenal hyperplasia . Current Opinion in Endocrinology, Diabetes, and Obesity 2016 23 225 – 2 32 . ( https://doi.org/10.1097/MED.0000000000000256 ) 6
Department of Endocrinology, The People’s Hospital of Daxing District, Beijing, China
Search for other papers by Ya-Fen Hu in
Google Scholar
PubMed
Search for other papers by Lin Hua in
Google Scholar
PubMed
Search for other papers by Xiu Tuo in
Google Scholar
PubMed
Search for other papers by Ting-Ting Shi in
Google Scholar
PubMed
Search for other papers by Yi-Lin Yang in
Google Scholar
PubMed
Search for other papers by Yun-Fu Liu in
Google Scholar
PubMed
Search for other papers by Zhong-Yu Yan in
Google Scholar
PubMed
Search for other papers by Zhong Xin in
Google Scholar
PubMed
OM enlargement) of GO patients. The findings might help to further explore the pathogenesis of this disease and provide novel treatment and prevention strategies. Materials and methods Study participants The present study was performed at
Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, The Netherlands
Search for other papers by Thomas Crezee in
Google Scholar
PubMed
Search for other papers by Mirela Petrulea in
Google Scholar
PubMed
Division of Endocrinology, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Search for other papers by Doina Piciu in
Google Scholar
PubMed
Department of Nuclear Medicine and Endocrine Tumors, Institute of Oncology ‘Prof. Dr. Ion Chiricuta’, Cluj-Napoca, Romania
Search for other papers by Martin Jaeger in
Google Scholar
PubMed
Search for other papers by Jan W A Smit in
Google Scholar
PubMed
Department of Nuclear Medicine and Endocrine Tumors, Institute of Oncology ‘Prof. Dr. Ion Chiricuta’, Cluj-Napoca, Romania
Search for other papers by Theo S Plantinga in
Google Scholar
PubMed
Endocrinology Clinic, Cluj County Emergency Hospital, Cluj-Napoca, Romania
Search for other papers by Carmen E Georgescu in
Google Scholar
PubMed
Department of Nuclear Medicine and Endocrine Tumors, Institute of Oncology ‘Prof. Dr. Ion Chiricuta’, Cluj-Napoca, Romania
Search for other papers by Romana Netea-Maier in
Google Scholar
PubMed
proliferation and dedifferentiation, partly by activation of autophagy, providing the rationale for application of novel treatment modalities targeting this oncogenic pathway ( 18 , 19 , 20 , 21 , 22 ). The PI3K kinase, encoded by the PIK3CA gene, is a